Proteomics Evidence of the Role of TDMQ20 in the Cholinergic System and Synaptic Transmission in a Mouse Model of Alzheimer’s Disease - Archive ouverte HAL Access content directly
Journal Articles ACS Chemical Neuroscience Year : 2022

Proteomics Evidence of the Role of TDMQ20 in the Cholinergic System and Synaptic Transmission in a Mouse Model of Alzheimer’s Disease

Abstract

The interaction between copper ions and amyloid peptide Aβ has been reported to be involved in Alzheimer’s disease (AD) pathology. Based on copper coordination biochemistry, we designed specific copper chelators [tetradentate monoquinolines (TDMQs)] in order to regulate copper homeostasis in the AD brain and inhibit the deleterious oxidative stress catalyzed by copper-Aβ complexes. We previously reported that TDMQ20, a highly selective copper chelator selected as a drug candidate, was able to extract copper from the Cu-Aβ1–16 complex and restore cognitive and behavioral deficits in AD mouse models. For a better understanding of the mechanism of action of TDMQ20, we decided to investigate the change of profile of proteins expressed in 5xFAD mice after an oral treatment of TDMQ20 (dose = 10 mg/kg, once every two days for 3 months, in total 45 times). Clioquinol (CQ), a non-specific chelator, has been used as a comparator. Here, we report the proteomic alterations in the cortex of 5xFAD mice using iTRAQ (isobaric tags for relative and absolute quantification) proteomics technology. The results indicated that 178 differentially expressed proteins (DEPs) have been identified in the AD mouse group with respect to wild type (WT) animals (AD/WT). After treatment by TDMQ20, 35 DEPs were found common in AD/WT and TDMQ20/AD groups in an opposite change manner (up- or down-regulated, respectively). In addition, among the 35 DEPs mentioned above, 10 common target proteins have been identified in AD/WT, TDMQ20/AD, and CQ/AD groups, among which 3 target proteins were successfully validated by western blot analysis. In particular, the expression levels of ChAT and CHRM4 are significantly increased upon TDMQ20 treatment with respect to 5xFAD mice, while CQ did not significantly change the expression of these proteins. Our study suggests the involvement of the copper chelator TDMQ20 on the cholinergic system, a feature that may explain the improved cognitive and behavioral performance in AD mice upon oral treatment of TDMQ20.
Fichier principal
Vignette du fichier
Sun, Proteomics evidence of the role of TDMQ20, 2022.pdf (716.2 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03826219 , version 1 (06-11-2023)

Identifiers

Cite

Fanfan Sun, Jie Zhao, Huajie Zhang, Qihui Shi, Yan Liu, et al.. Proteomics Evidence of the Role of TDMQ20 in the Cholinergic System and Synaptic Transmission in a Mouse Model of Alzheimer’s Disease. ACS Chemical Neuroscience, 2022, 13 (21), pp.3093-3107. ⟨10.1021/acschemneuro.2c00455⟩. ⟨hal-03826219⟩
47 View
52 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More